Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigious | ||
Readability |
H.S. freshman Avg
|
New words:
Abbokinase, Abbott, back, billion, biotherapeutic, bond, broad, CAFC, CEO, colorectal, concentration, concluded, created, critical, Crohn, dat, degeneration, Direc, disclosure, endpoint, entirety, entry, exit, Februa, fi, furt, Germany, gistered, halting, headcount, intermediate, liabilit, llion, ly, macular, Medicinal, mi, mild, Millennium, moderate, nancing, narrower, nition, onetary, oth, overturn, panel, Penzberg, pledged, post, ppeal, pr, prospectively, Proxy, pursue, randomized, ranibizumab, recog, redeclared, reintroduction, reserve, reserved, restructuring, retention, reversal, rhuFab, ry, serum, shortfall, similar, site, sooner, suggested, surety, survival, system, talented, ulcerative, unexpected, urokinase, wet, whichever, Xeloda
Filing tables
Filing exhibits
Genentech similar filings
Filing view
External links